Secondary endpoints included changes in seizure frequency , responder rate ( @ % decrease in seizure frequency ) , Centre for Epidemiologic Studies Depression scale ( CES-D ) , Neurological Disorders Depression Inventory-Epilepsy scale ( NDDI-E ) , Clinical Global Impression-Improvement scale ( CGI-I ) , Adverse Event Profile ( AEP ) , and antiepileptic drug ( AED ) load .